Yüklüyor......
Lenalidomide-Associated Immune Thrombocytopenia: A Case Report and Review of the Literature
Lenalidomide is indicated in the front-line management of multiple myeloma. More recently, it has been introduced for use in treating other hematologic malignancies. Although the drug is known to cause myelosuppression, there have been rare reports of lenalidomide-associated immune thrombocytopenia...
Kaydedildi:
| Yayımlandı: | Case Rep Hematol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7676979/ https://ncbi.nlm.nih.gov/pubmed/33274089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8825618 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|